-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Downgrades Lifecore Biomedical to Market Perform

Benzinga·09/29/2026 16:04:11
Listen to the news
Barrington Research analyst Michael Petusky downgrades Lifecore Biomedical (NASDAQ:LFCR) from Outperform to Market Perform.